29
1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland [email protected] 301-443-3314 ext. 132 Update on Proposed Amendments to the Performance Standard for Diagnostic X-ray Systems (21 CFR 1020.30 - .33) (The Fluoroscopic System Amendments)

1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland [email protected]

Embed Size (px)

Citation preview

Page 1: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

1

Thomas B. ShopeOffice of Science and Technology

Center for Devices and Radiological HealthU.S. Food and Drug Administration

Rockville, Maryland

[email protected] ext. 132

Update on Proposed Amendments

to the Performance Standard for Diagnostic X-ray Systems

(21 CFR 1020.30 - .33)(The Fluoroscopic System Amendments)

Page 2: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

2

Outline

Background on amendment development.

Status of comments.

Estimated schedule for completion.

Future role of international standards?

Advice or comment from the committee

Page 3: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

3

Background

Community recognized need for amendments to address changes in technology in early 1990s• Increased radiation output capability and new imaging

modes• Digital subtraction angiography, lithotripsy systems• 1992 ACR/FDA Workshop on Fluoroscopy

► Consensus on need for display of patient dose info Development of IEC Standard 60601-2-43: Particular

requirements for the safety of X-ray equipment for interventional procedures

Concerns over radiation injuries from fluoroscopy

Page 4: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

4

FDA’s Actions Regarding Fluoroscopic X-ray

Systems 1993 - Proposed rule regarding limit on maximum

exposure rate during high-level control mode 1995 - Final rule effective, other amendments needed 1997 - ANPR for additional amendments published Discussion of concepts for amendments and proposed

rule with TEPRSSC at 1997 and 1998 meetings “Year 2000 Problem” diverts resources/delays

progress

Page 5: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

5

FDA’s Actions Regarding Fluoroscopic X-ray

Systems December 2002 - Proposed rule published following

development of impact analysis, estimates of costs and benefits

Comment period ended April 10, 2003

FDA consideration of comments

Preparation of Final Rule

Page 6: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

6

Comments on proposed rule

Comments from 12 individuals or organizations• Two state agencies• Three professional associations• One industry association• Two x-ray equipment manufacturers• Four individuals, including one medical physicist

and one radiation effects researcher Comments, in general, were in favor of

amendments

Page 7: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

7

Comments on proposed rule

Some objections to specific proposals or details Changes suggested to the standard that were not

part of FDA’s proposal - Such changes would generally require an additional proposal for comment• Definitions, clarifications, significant changes

Several comments urged “harmoniztion” with IEC standards for x-ray equipment

Page 8: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

8

Examples of specific comments

Modify definitions Desire to consult/confer with FDA on development

of additional requirements• Dose limits for input to the image receptor• Imaging performance• Characterization and requirements for solid state

x-ray imaging devices

Page 9: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

9

Comments on Definitions

Attenuation block - size, thickness Mode of operation - single control in IEC standard C-arm fluoroscope Exposure - definition of second meaning (loading) Isocenter Solid state x-ray imaging device Visible area Others

Page 10: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

10

Critiques of proposed requirements

Manufacturer description of intended uses for specific modes of operation in user information

Manner and accuracy of dose display data Ultimate responsibility for modifications initiated by

user/owner Audible signal during fluoroscopy - conflict with

current IEC standard 60601-2-7 for generators Application of dose display and last image hold to

mini C-arm systems (SID < 45 cm)

Page 11: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

11

Reference location for system with isocenter

Shield

Shield

Monitor

15 cm

Dose rate orcumulative doseat reference point

Page 12: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

12

8.3mGy/minmGy

During irradiationAir kerma rate

mGy/minmGy66.8

Following irradiationCumulative air kerma

Proposed display of dose information

Page 13: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

13

mGy/min

mGy

Air kerma rate

Cumulative air kerma

Display of air kerma rate during irradiation.

Continuous display of cumulative air kerma.

Alternative display of dose information

4.8

127.5

Page 14: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

14

Accuracy of dose display?

Proposed accuracy of display of 25%

IEC Standard 60601-2-43 requires 50%

Is an accuracy of better than 50% necessary?

Page 15: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

15

Critiques of proposed requirements

Manufacturer description of intended uses for specific modes of operation in user information

Manner and accuracy of dose display data Ultimate responsibility for modifications initiated by

user/owner Audible signal during fluoroscopy - conflict with

current IEC standard 60601-2-7 for generators Application of dose display and last image hold to

mini C-arm systems (SID < 45 cm)

Page 16: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

16

Additional changes not in NPR

Require info and tools for troubleshooting, repair, service, and testing

Specification of voltage (kVp) waveform Use specific IEC requirements - dose info, test

procedures, primary protective barrier Display peak skin dose and “skin dose map” Display of collimation without irradiation Indication of x-ray beam-on and “live image” Post-exposure “image cropping” of digital images

Page 17: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

17

Skin dose “mapping” system

Page 18: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

18

Additional changes not in NPR

Require info and tools for troubleshooting, repair, service, and testing

Specification of voltage (kVp) waveform Use specific IEC requirements - dose info, test

procedures, primary protective barrier Display peak skin dose and “skin dose map” Display of collimation without irradiation Indication of x-ray beam-on and “live image” Post-exposure “image cropping” of digital images

Page 19: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

19

Electronic “cropping” of digital images

Area of imagereceptor

X-ray field area

Area of stored image

Page 20: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

20

Electronic “cropping” of digital images

Stored and displayed image

X-ray field

Page 21: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

21

“Cropping” of poorly collimated image

Area of imagereceptor

X-ray field

Area of stored image

Page 22: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

22

X-ray field border

Stored and displayed image

“Cropping” of poorly collimated image

Page 23: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

23

Question?

Are requirements about “electronic cropping” of digital images needed in performance standards for digital diagnostic x-ray systems?

Initial display versus storage of images?

Page 24: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

24

Errors and omissions noted

Discussion of “unique” modes of operation and dose information for them

Omission of effective date for 1020.32(m)(2) and clarification of requirement to indicate filtration used

Attenuation of material between patient and image receptor

Tolerance on dose display data - 1020.30(h)(6)(i) Typo in proposed 1020.32(k)(5)(ii) describing the

alternate location of the reference point

Page 25: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

25

Schedule for completion

Finalize decisions regarding regulatory wording

Draft Federal Register notice for final rule that responds to comments

CDRH, FDA, HHS and OMB review of FR notice

Anticipate completion by end of calendar 2003, rule would be effective in late 2004 or early 2005.

Page 26: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

26

Future role of international (IEC)

standards? Relationship between U.S. and IEC standards needs attention in global economy?• No IEC standards when U.S. std. Developed• Process for developing IEC standards different from

the regulatory process►Consensus of national committees►Maintenance teams - structure being revised

• Are IEC standards “enforced” on manufacturers?• FDA standards address only radiation safety

performance

Page 27: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

27

Future role of international (IEC)

standards? Could IEC standards be used in place of U.S.

standards (for medical x-ray, for other electronic products)?• How could they be enforced?• Impact on State radiation control programs?• Impact on Federal preemption?• Could medical device authorities be used to

assure compliance with “voluntary” IEC stds?

Page 28: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

28

Future role of international (IEC)

standards?• Could IEC standards be used without legislative

changes?• Would public health be protected if reliance

placed on IEC standards?• Could FDA or U.S. national committee play

effective role in maintenance of IEC standards? • Do current problems with Dx x-ray systems

warrant continued mandatory standard?• Would greater public health impact be obtained

through other FDA activities?

Page 29: 1 Thomas B. Shope Office of Science and Technology Center for Devices and Radiological Health U.S. Food and Drug Administration Rockville, Maryland tbs@cdrh.fda.gov

29

Comments & Questions